Find a Vaccination Clinic | ViVAXIM® Combined Purified Vi Polysaccharide Typhoid and Inactivated Heptatitis A Vaccine

Indication and Safety Information

ViVAXIM^® is a vaccine for the simultaneous prevention of infection caused by S. typhi, the organism that causes typhoid fever, and hepatitis A virus (HAV) in persons 16 years of age or older. ViVAXIM^® may be used as a booster vaccine in persons who received ViVAXIM^® 36 months earlier and who require a hepatitis A booster and a repeat dose of typhoid vaccine.

For long-term protection against HAV, a booster dose of an inactivated hepatitis A vaccine should be given 6 to 36 months following ViVAXIM^®. For persons who remain at risk of typhoid fever, a repeat dose of typhoid vaccine should be given every 3 years.

The most common side effects are pain, swelling and redness at the injection site, headache, muscle ache and fatigue. As with all vaccines, ViVAXIM^® may not protect 100% of individuals and does not treat existing infections. For more information, visit www.sanofi.ca or access the product monograph at: products.sanofi.ca/en/vivaxim.pdf

VACCINATION
CLINIC

VACCINATION
CLINIC

It’s a good idea to call ahead to confirm availability.

Indication and Safety Information

VACCINATIONCLINIC

VACCINATIONCLINIC

It’s a good idea to call ahead to confirm availability.

Indication and Safety Information

VACCINATION
CLINIC

VACCINATION
CLINIC